2 results
Approved WMOCompleted
ARA290 is a new drug against neuropathic pain and was succesfully tested in previous studies on patients with neuropathic pain due to diabetes and sarcoidosis. The current study involves sarcoidosis patients with pain due to neuropathy. The purpose…
Approved WMOCompleted
To assess the analgesic effect of ARA290 in chronic pain patients